Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Farah Al-Sahlawi"'
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-12 (2024)
Background: Gefitinib (GEF) is a tyrosine kinase inhibitor that has proven good efficacy against Non-small cell Lung Carcinoma (NSCLC). It has low solubility and dissolution rate and low oral bioavailability. This work aimed to improve efficacy by lo
Externí odkaz:
https://doaj.org/article/14dc9029158a4086b146d986ec6b684a
Autor:
Al-Sahlawi, Farah1,2, Mahmood Alabdali, Aya Yaseen3, Chinnappan, Sasikala1 sasikala@ucsiuniversity.edu.my, Al-Samydai, Ali, Abdelkarim Maki, Marwan Abdelmahmoud1,4 marwanaamaki@gmail.com
Publikováno v:
Journal of Applied Pharmaceutical Science. Sep2024, Vol. 14 Issue 9, p057-068. 12p.
Publikováno v:
Respiratory Therapeutics Week; 2/12/2024, p1287-1287, 1p